China Universal Asset Management Co., Ltd. Rocket Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,505 shares of RCKT stock, worth $205,858. This represents 0.04% of its overall portfolio holdings.
Number of Shares
17,505
Previous 10,666
64.12%
Holding current value
$205,858
Previous $229,000
41.05%
% of portfolio
0.04%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding RCKT
# of Institutions
209Shares Held
93.2MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$208 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$132 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$72.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$65.1 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$52.8 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $890M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...